John Peter Stefano Holden

Touchstone Innovations Ltd. engages in the provision of technology and commercialization services. The company was founded by Susan Jane Searle in 1986 and is headquartered in London, the United Kingdom.

RepRegen Ltd. develops synthetic, biologically-active and tissue engineering products. Its smart biomaterials are designed both to support and to improve cellular growth in vivo. The firm is an emerging medical device company using patent-pending repair and regeneration technology in two platforms designed to mend and regrow tissue in the body. RepRegen's first platform is focused on bone and other (hard) tissue, whereas the second platform is focused on muscle and other (soft) tissue. The company was founded in June 2006 and is headquartered in London, GB.

OSspray Ltd. provides bioactive powders for teeth cutting, cleaning and whitening. It engages in the innovation of biomaterials for minimally invasive dentistry of therapeutic air polishing solutions that restore and maintain tooth structure and overall oral health. The company was founded in 2004 by Paul Robinson, Larry Hench and Ian Dennis Thompson and is headquartered in London, GB.

Veryan Medical Ltd. develops and commercializes novel vascular stent technology. The firm's products are designed to clinical performance and bio-mechanical performance of stented vessels. The company was founded by Colin G. Caro, Charles Richard Taylor and Paul Burke Gilson in 2003 and is headquartered in Oxford, the United Kingdom.

Cortexica Vision Systems Ltd. develops image recognition and visual search technology which uses algorithms that mimic the way the human brain recognizes images and objects. The firm’s image search algorithms adapt in real-time to local stimulus patterns and employ a variety of customized wavelet constructions to generate image search and video search results. Its products include findSimilar fashion and findSimilar shoes. The firm operates through its offices located in London and San Francisco. The company was founded by Jeffrey Ng Sing Kwong, Scott White Darren and Anil Anthony Bharath in 2008 and is headquartered in London, the United Kingdom.

3i Venture Capital (3i VC) is the venture capital division of 3i Investments Plc, ultimately owned by 3i Group Plc (LSE: III) in Great Britain. Created in 2001 when 3i aligned their organizational structure along global business lines, 3i VC invests globally in seed- to late-stage technology and healthcare businesses. Based in London, the firm has additional offices in Birmingham, Cambridge, Paris, Boston, San Francisco, Stockholm, Hong Kong, Stuttgart and Munich.